CIK 0001799191 · Accelerated filer<br>Smaller reporting company
Starling Oncology, Inc.
Sign in to watch- Tickers
- STLN DFPH
- Exchange
- Nasdaq, OTC
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843562323
- Phone
- 562-735-3226
- Business address
- 18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
- Former names
- Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.
Securities
- STLN Common Stock Nasdaq
- STLNW Warrant Nasdaq
- DFPH Common stock OTC
- Open-market buys, last 90 days
- $176,273
- in 1 filing
- Open-market sales, last 90 days
- $13,322,043
- in 2 filings, $1.9M under 10b5-1 plans
Net −$13,145,770. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-20 | McGeorge Anne Director | Grant or award | +67,901 | 251,247 | ||
| 2025-11-20 | McGeorge Anne Director | Grant or award | +40,123 | 291,370 | ||
| 2025-11-20 | Kaushal Mohit Director | Grant or award | +50,926 | 228,179 | ||
| 2025-11-20 | Kaushal Mohit Director | Grant or award | +40,123 | 268,302 | ||
| 2025-11-20 | Ling Gabriel Director | Grant or award | +46,296 | 296,502 | ||
| 2025-11-20 | Ling Gabriel Director | Grant or award | +37,037 | 333,539 | ||
| 2025-11-20 | Johnson Karen Marie Director | Grant or award | +47,840 | 251,249 | ||
| 2025-11-20 | Johnson Karen Marie Director | Grant or award | +37,037 | 288,286 | ||
| 2025-11-20 | Pacala Mark L Director | Grant or award | +46,296 | 221,267 | ||
| 2025-11-20 | Pacala Mark L Director | Grant or award | +35,494 | 256,761 | ||
| 2025-11-20 | Hively Brad Director | Grant or award | +41,667 | 664,647 | ||
| 2025-11-20 | Hively Brad Director | Grant or award | +32,407 | 697,054 | ||
| 2025-11-18 | Ling Gabriel Director | Other acquisition | +141,149 | 250,206 | ||
| 2025-11-18 | M33 Growth I L.P. Director | Other disposition | −590,892 | 0 | ||
| 2025-11-18 | M33 Growth I L.P. Director | Other acquisition | +11,818 | 7,944,207 | ||
| 2025-11-18 | M33 Growth I L.P. Director | Other disposition | −2,500,000 | 5,444,207 | ||
| 2025-11-18 | Pacala Mark L Director | Sale | −2,160 | $4.00 | $9K | 222,811 |
| 2025-11-18 | Pacala Mark L Director | Sale | −1,210 | $4.00 | $5K | 221,601 |
| 2025-11-18 | Pacala Mark L Director | Sale | −46,630 | $4.00 | $187K | 174,971 |
| 2025-11-17 | Virnich Daniel Chief Executive Officer | Grant or award | +6,464 | 1,799,984 |
Page 4 of 8 · 157 trades